Cyclic adenosine monophosphate response element- binding protein phosphorylation and neuroprotection by 4-phenyl-1-(4-phenylbutyl) piperidine (ppbp)

Anesthesia and Analgesia

Volumn 108, Issue 3, 2009, Pages 964-970

  Yang, Sufang ^a   Alkayed, Nabil J ^a   Hurn, Patricia D ^a   Kirsch, Jeffrey R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 PHENYL 1 (4 PHENYLBUTYL) PIPERIDINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOSE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; OPIATE AGONIST; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; RIMCAZOLE; UNCLASSIFIED DRUG; 1,3 BUTADIENE DERIVATIVE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 4 PHENYL 1 (4 PHENYLBUTYL)PIPERIDINE; 4-PHENYL-1-(4-PHENYLBUTYL)PIPERIDINE; CHROMONE DERIVATIVE; DRUG DERIVATIVE; HALOPERIDOL; ISOQUINOLINE DERIVATIVE; MORPHOLINE DERIVATIVE; NEUROPROTECTIVE AGENT; NITRILE; PROTEIN KINASE INHIBITOR; SIGMA 1 OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR; SULFONAMIDE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CELL DEATH; COMPUTER PROGRAM; CONTROLLED STUDY; EMBRYO; IMAGE ANALYSIS; IMMUNOBLOTTING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REOXYGENATION; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL HYPOXIA; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NERVE CELL; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BUTADIENES; CELL DEATH; CELL HYPOXIA; CELLS, CULTURED; CHROMONES; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLUCOSE; HALOPERIDOL; ISOQUINOLINES; MORPHOLINES; NEURONS; NEUROPROTECTIVE AGENTS; NITRILES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; SULFONAMIDES;

EID: 61949485070     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318192442c     Document Type: Article

References (36)

1. Maurice T, Phan VL, Urani A, Kamei H, Noda Y, Nabeshima T. Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol 1999;81:125-55
2. Walker JM, Bowen WD, Walker FO, Matsumoto RR, De CB, Rice KC. Sigma receptors: biology and function. Pharmacol Rev 1990;42:355-402
3. Lesage AS, De Loore KL, Peeters L, Leysen JE. Neuroprotective sigma ligands interfere with the glutamate-activated NOS pathway in hippocampal cell culture. Synapse 1995;20:156-64
4. Yang S, Bhardwaj A, Cheng J, Alkayed NJ, Hurn PD, Kirsch JR. Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2. Anesth Analg 2007;104:1179-84
5. Harukuni I, Bhardwaj A, Traystman RJ, Crain B, London ED, Kirsch JR. Neuroprotection from focal ischemia by 4-phenyl-1- (4-phenylbutyl) piperidine (PPBP) is dependent on treatment duration in rats. Anesth Analg 1998;87:1299-305
6. Takahashi H, Kirsch JR, Hashimoto K, London ED, Koehler RC, Traystman RJ. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats. Stroke 1995;26:1676-82
7. Takahashi H, Kirsch JR, Hashimoto K, London ED, Koehler RC, Traystman RJ. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats. Stroke 1996;27:2120-3
8. Takahashi H, Traystman RJ, Hashimoto K, London ED, Kirsch JR. Postischemic brain injury is affected stereospecifically by pentazocine in rats. Anesth Analg 1997;85:353-7
9. Sugimoto K, Iadecola C. Effects of aminoguanidine on cerebral ischemia in mice: comparison between mice with and without inducible nitric oxide synthase gene. Neurosci Lett 2002;331:25-8
10. Bhardwaj A, Sawada M, London ED, Koehler RC, Traystman RJ, Kirsch JR. Potent sigma1-receptor ligand 4-phenyl-1-(4- phenylbutyl) piperidine modulates basal and N-methyl-daspartate- evoked nitric oxide production in vivo. Stroke 1998;29:2404-10
11. Meller R, Minami M, Cameron JA, Impey S, Chen D, Lan JQ, Henshall DC, Simon RP. CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab 2005;25:234-46
12. Brindle PK, Montminy MR. The CREB family of transcription activators. Curr Opin Genet Dev 1992;2:199-204
13. Martin KC, Kandel ER. Cell adhesion molecules, CREB, and the formation of new synaptic connections. Neuron 1996;17:567-70
14. Hu BR, Fux CM, Martone ME, Zivin JA, Ellisman MH. Persistent phosphorylation of cyclic AMP responsive element-binding protein and activating transcription factor-2 transcription factors following transient cerebral ischemia in rat brain. Neuroscience 1999;89:437-52
15. Beitner-Johnson D, Millhorn DE. Hypoxia induces phosphorylation of the cyclic AMP response element-binding protein by a novel signaling mechanism. J Biol Chem 1998;273:19834-9
16. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999;286:1358-62
17. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JE. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 2000;275:10761-6
18. Sun P, Enslen H, Myung PS, Maurer RA. Differential activation of CREB by Ca2-/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev 1994;8:2527-39
19. Walton M, Woodgate AM, Muravlev A, Xu R, During MJ, Dragunow M. CREB phosphorylation promotes nerve cell survival. J Neurochem 1999;73:1836-42
20. Zanassi P, Paolillo M, Feliciello A, Avvedimento EV, Gallo V, Schinelli S. cAMP-dependent protein kinase induces cAMPresponse element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons. J Biol Chem 2001;276:11487-95
21. Xiong ZG, Zhu XM, Chu XP, Minami M, Hey J, Wei WL, MacDonald JF, Wemmie JA, Price MP, Welsh MJ, Simon RP. Neuroprotection in ischemia: blocking calcium-permeable acidsensing ion channels. Cell 2004;118:687-98
22. Hayashi T, Su TP. An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma 1 receptor ligand. Expert Opin Ther Targets 2008;12:45-58
23. Walton MR, Dragunow I. Is CREB a key to neuronal survival? Trends Neurosci 2000;23:48-53
24. Walton M, Sirimanne E, Williams C, Gluckman P, Dragunow M. The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic-ischemic brain damage and repair. Brain Res Mol Brain Res 1996;43:21-9
25. Tanaka K, Nogawa S, Nagata E, Suzuki S, Dembo T, Kosakai A, Fukuuchi Y. Temporal profile of CREB phosphorylation after focal ischemia in rat brain. Neuroreport 1999;10:2245-50
26. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-41
27. Du K, Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 1998;273:32377-9
28. Mao L, Tang Q, Samdani S, Liu Z, Wang JQ. Regulation of MAPK/ERK phosphorylation via ionotropic glutamate receptors in cultured rat striatal neurons. Eur J Neurosci 2004; 19:1207-16
29. Greenwood JM, Dragunow M. Muscarinic receptor-mediated phosphorylation of cyclic AMP response element binding protein in human neuroblastoma cells. J Neurochem 2002;82:389-97
30. Kobayashi M, Lust WD, Passonneau JV. Concentrations of energy metabolites and cyclic nucleotides during and after bilateral ischemia in the gerbil cerebral cortex. J Neurochem 1977;29:53-9
31. Parker D, Ferreri K, Nakajima T, LaMorte VJ, Evans R, Koerber SC, Hoeger C, Montminy MR. Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol 1996;16:694-703
32. Mabuchi T, Kitagawa K, Kuwabara K, Takasawa K, Ohtsuki T, Xia Z, Storm D, Yanagihara T, Hori M, Matsumoto M. Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J Neurosci 2001;21:9204-13
33. Haribabu B, Hook SS, Selbert MA, Goldstein EG, Tomhave ED, Edelman AM, Snyderman R, Means AR. Human calciumcalmodulin dependent protein kinase I: cDNA cloning, domain structure and activation by phosphorylation at threonine-177 by calcium-calmodulin dependent protein kinase I kinase. EMBO J 1995;14:3679-86
34. Selbert MA, Anderson KA, Huang QH, Goldstein EG, Means AR, Edelman AM. Phosphorylation and activation of Ca(2-)- calmodulin-dependent protein kinase IV by Ca(2-)-calmodulindependent protein kinase Ia kinase. Phosphorylation of threonine 196 is essential for activation. J Biol Chem 1995;270:17616-21
35. Enslen H, Sun P, Brickey D, Soderling SH, Klamo E, Soderling TR. Characterization of Ca2-/calmodulin-dependent protein kinase IV. Role in transcriptional regulation. J Biol Chem 1994;269:15520-7
36. Lochner A, Moolman JA. The many faces of H89: a review. Cardiovasc Drug Rev 2006;24:261-74